Display Settings:

Format

Send to:

Choose Destination

    Arthritis Res Ther. 2009;11(3):233. Epub 2009 Jun 25.

    Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?

    Melis L, Elewaut D.

    Department of Rheumatology, Ghent University Hospital, 0K12IB, De Pintelaan 185, 9000 Ghent, Belgium. lode.melis@ugent.be

    Spondyloarthritides, or SpA, form a cluster of chronic inflammatory diseases with the axial skeleton as the most typical disease localisation, although extra-articular manifestations such as intestinal inflammation may frequently occur during the course of the disease. This review summarises recent progress in our understanding of the immunopathogenesis of SpA with special emphasis on the cellular constituents considered to be responsible for the initiation and/or perpetuation of inflammation. There are several arguments favouring a role for haematopoietic cells in the pathophysiology of spondyloarthritis, including HLA-B27-associated dendritic cell disturbances, HLA-B27 misfolding properties and T helper 17 cells. In addition, recent studies have pointed toward a pivotal role for stromal cells. A major challenge, however, remains to determine how recently identified genetic associations such as interleukin-23 receptor polymorphisms may influence cellular targets in spondyloarthritis.

    PMID: 19591637 [PubMed - in process]

    PMCID: PMC2714138

    Supplemental Content

    Click here to read Click here to read